Addressing Global Differences in HCC Risk Factors and Management Strategies

Although significant advances have been made in multidisciplinary and individualized screening and treatments for HCC, such sophisticated methods are relatively expensive and therefore remain beyond the reach of many patients in less economically developed countries where local resources and healthcare budget are limited. To address the global differences in treatment provision, the journal Editors are seeking to publish multidisciplinary clinical and translational studies, cost-effective screening and treatment strategies and consensus statements, including those which consider available local resources.